Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression

Silvestri M., Fregonese L., Sabatini F., Dasic G., Rossi G.A.

Source: Eur Respir J 2001; 18: 139-145
Journal Issue: July
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Silvestri M., Fregonese L., Sabatini F., Dasic G., Rossi G.A.. Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur Respir J 2001; 18: 139-145

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proliferation is not increased in airway myofibroblasts isolated from asthmatics
Source: Eur Respir J 2008; 32: 362-371
Year: 2008



Inhibitory activities of fluticasone propionate and salmeterol on airway epithelial cell functions (FLIC24): adhesion molecule expression and cytokine release
Source: Eur Respir J 2001; 18: Suppl. 33, 246s
Year: 2001

Effect of beclomethasone dipropionate, formoterol and their combination on TNF-α-induced ICAM-1 and IL-8 expression in human bronchial epithelial cells
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 690s
Year: 2004

Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Nasal fibroblast functions involved in airway inflammation and remodelling are downregulated by fluticasone propionate (FP)
Source: Eur Respir J 2001; 18: Suppl. 33, 147s
Year: 2001

Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects
Source: Eur Respir J 2002; 19: 257-266
Year: 2002



Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011

Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003

Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002

Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 101s
Year: 2004

IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013

Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells
Source: Eur Respir J 2008; 31: 1313-1321
Year: 2008



Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
Source: Eur Respir J 2007; 30: 653-661
Year: 2007



Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011


The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

Downregulation of TNF-α induced E-selectin expression by beclomethasone dipropionate and formoterol in human endothelial cells
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids
Source: Eur Respir J 2011; 38: 1044-1052
Year: 2011



Inhibitory activity of fluticasone propionate (FP), on the constitutive or cytokine-induced bronchial epithelial cell (HBECs) functions in vitro
Source: Eur Respir J 2003; 22: Suppl. 45, 76s
Year: 2003

Formoterol reduces asthmatic airway smooth muscle cell proliferation through p27 (Kip) which is supported by steroids
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012